Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Deepak L. Bhatt, M.D.

Co-Author

This page shows the publications co-authored by Deepak Bhatt and Muthiah Vaduganathan.
Connection Strength

25.254
  1. Vaduganathan M, Singh A, Sharma A, Januzzi JL, Scirica BM, Butler J, Zannad F, McGuire DK, Cannon CP, Bhatt DL. Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk. Am J Cardiol. 2020 May 15; 125(10):1577-1581.
    View in: PubMed
    Score: 0.985
  2. Vaduganathan M, Patel RB, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. J Am Coll Cardiol. 2019 04 02; 73(12):1596-1598.
    View in: PubMed
    Score: 0.924
  3. Vaduganathan M, Sathiyakumar V, Singh A, McCarthy CP, Qamar A, Januzzi JL, Scirica BM, Butler J, Cannon CP, Bhatt DL. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 12 25; 72(25):3370-3372.
    View in: PubMed
    Score: 0.907
  4. Vaduganathan M, Pareek M, Qamar A, Pandey A, Olsen MH, Bhatt DL. The Reply. Am J Med. 2018 09; 131(9):e389-e390.
    View in: PubMed
    Score: 0.881
  5. Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. The Reply. Am J Med. 2018 06; 131(6):e263.
    View in: PubMed
    Score: 0.872
  6. Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. The Reply. Am J Med. 2018 06; 131(6):e267-e268.
    View in: PubMed
    Score: 0.872
  7. Vaduganathan M, Pareek M, Qamar A, Pandey A, Olsen MH, Bhatt DL. Baseline Blood Pressure, the 2017 ACC/AHA High Blood Pressure Guidelines, and Long-Term Cardiovascular Risk in SPRINT. Am J Med. 2018 08; 131(8):956-960.
    View in: PubMed
    Score: 0.853
  8. Vaduganathan M, Harrington RA, Stone GW, Steg G, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials. EuroIntervention. 2018 02 02; 13(15):e1841-e1849.
    View in: PubMed
    Score: 0.852
  9. Vaduganathan M, Qamar A, Badreldin HA, Faxon DP, Bhatt DL. Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock. JACC Cardiovasc Interv. 2017 12 11; 10(23):2468-2469.
    View in: PubMed
    Score: 0.844
  10. Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am J Med. 2018 05; 131(5):575-577.
    View in: PubMed
    Score: 0.843
  11. Vaduganathan M, Qamar A, Badreldin HA, Faxon DP, Bhatt DL. Cangrelor Use in Cardiogenic Shock: A Single-Center Real-World Experience. JACC Cardiovasc Interv. 2017 08 28; 10(16):1712-1714.
    View in: PubMed
    Score: 0.827
  12. Vaduganathan M, Bhatt DL. Cardiac Troponins in Chronic Kidney Disease: A Marker of Global Cardiovascular Risk. Am J Nephrol. 2017; 45(4):301-303.
    View in: PubMed
    Score: 0.797
  13. Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials. JAMA Cardiol. 2017 02 01; 2(2):127-135.
    View in: PubMed
    Score: 0.795
  14. Vaduganathan M, Bhatt DL. Gastrointestinal Bleeding With Oral Anticoagulation: Understanding the Scope of the Problem. Clin Gastroenterol Hepatol. 2017 05; 15(5):691-693.
    View in: PubMed
    Score: 0.792
  15. Vaduganathan M, Qamar A, Singh A, Venkateswaran RV, Szumita PM, Croce KJ, Mauri L, Leopold JA, Shah PB, Sobieszczyk P, Faxon DP, Bhatt DL. Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. J Am Coll Cardiol. 2017 01 31; 69(4):463-464.
    View in: PubMed
    Score: 0.786
  16. Vaduganathan M, Pareek M, Bhatt DL. Gastroprotection with proton-pump inhibitors in high-risk cardiovascular patients: who to target and for how long? Expert Opin Drug Saf. 2016 Nov; 15(11):1451-1453.
    View in: PubMed
    Score: 0.772
  17. Vaduganathan M, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Prats J, Deliargyris EN, Mahaffey KW, White HD, Bhatt DL. Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial. Circ Cardiovasc Interv. 2016 06; 9(6).
    View in: PubMed
    Score: 0.759
  18. Vaduganathan M, Bhatt DL. Elevated Troponin Levels in Stable Patients Undergoing Hemodialysis: A Red Flag or a Red Herring? Am J Nephrol. 2016; 43(3):170-2.
    View in: PubMed
    Score: 0.752
  19. Vaduganathan M, Bhatt DL. Simultaneous Platelet P2Y12 and P2Y1 ADP Receptor Blockade: Are Two Better Than One? Arterioscler Thromb Vasc Biol. 2016 Mar; 36(3):427-8.
    View in: PubMed
    Score: 0.746
  20. Vaduganathan M, Venkataramani AS, Bhatt DL. Moving Toward Global Primordial Prevention in Cardiovascular Disease: The Heart of the Matter. J Am Coll Cardiol. 2015 Oct 06; 66(14):1535-1537.
    View in: PubMed
    Score: 0.725
  21. Vaduganathan M, Bhatt DL. Heads Up! Introducing Wearable Health Technologies in Cardiology. J Invasive Cardiol. 2015 Oct; 27(10):447.
    View in: PubMed
    Score: 0.725
  22. Vaduganathan M, Bhatt DL. Revisiting the Clopidogrel-Proton Pump Inhibitor Interaction: From Bench to Bedside. Circ Cardiovasc Interv. 2015 Oct; 8(10).
    View in: PubMed
    Score: 0.725
  23. Vaduganathan M, Bhatt DL. Aspirin and proton-pump inhibitors: interpreting the interplay. Eur Heart J Cardiovasc Pharmacother. 2016 01; 2(1):20-2.
    View in: PubMed
    Score: 0.723
  24. Vaduganathan M, Bhatt DL. Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: decongesting the matter. Eur Heart J. 2015 Jun 21; 36(24):1497-8.
    View in: PubMed
    Score: 0.711
  25. Vaduganathan M, Bhatt DL. Manual thrombectomy in myocardial infarction: aspiring for better. J Am Heart Assoc. 2015 Jun 15; 4(6):002201.
    View in: PubMed
    Score: 0.710
  26. Vaduganathan M, Bhatt DL. Manual Thrombectomy in Myocardial Infarction: Aspiring for Better. J Am Heart Assoc. 2015; 4(6).
    View in: PubMed
    Score: 0.710
  27. DeFilippis EM, Bajaj NS, Singh A, Malloy R, Givertz MM, Blankstein R, Bhatt DL, Vaduganathan M. Marijuana Use in Patients With Cardiovascular Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Jan 28; 75(3):320-332.
    View in: PubMed
    Score: 0.244
  28. Vaduganathan M, McCarthy CP, Ayers C, Bhatt DL, Kumbhani DJ, de Lemos JA, Fonarow GC, Pandey A. Longitudinal trajectories of hospital performance across targeted cardiovascular conditions in the USA. Eur Heart J Qual Care Clin Outcomes. 2020 Jan 01; 6(1):62-71.
    View in: PubMed
    Score: 0.243
  29. Byrne C, Pareek M, Vaduganathan M, Biering-Sørensen T, Qamar A, Pandey A, Olesen TB, Olsen MH, Bhatt DL. Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial. Eur Heart J Cardiovasc Pharmacother. 2019 Sep 14.
    View in: PubMed
    Score: 0.238
  30. McCarthy CP, Murphy S, Venkateswaran RV, Singh A, Chang LL, Joice MG, Rivero JM, Vaduganathan M, Januzzi JL, Bhatt DL. Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. J Am Coll Cardiol. 2019 04 23; 73(15):2007-2009.
    View in: PubMed
    Score: 0.230
  31. Oxlund CS, Pareek M, Rasmussen BSB, Vaduganathan M, Biering-Sørensen T, Byrne C, Almarzooq Z, Olsen MH, Bhatt DL. Body Mass Index, Intensive Blood Pressure Management, and Cardiovascular Events in the SPRINT Trial. Am J Med. 2019 07; 132(7):840-846.
    View in: PubMed
    Score: 0.228
  32. Pareek M, Vaduganathan M, Biering-Sørensen T, Byrne C, Qamar A, Almarzooq Z, Pandey A, Olsen MH, Bhatt DL. Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Med. 2019 06; 132(6):733-739.
    View in: PubMed
    Score: 0.228
  33. Kumar N, Simek S, Garg N, Vaduganathan M, Kaiksow F, Stein JH, Fonarow GC, Pandey A, Bhatt DL. Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency. Hypertension. 2019 01; 73(1):60-67.
    View in: PubMed
    Score: 0.227
  34. Patel RB, Venkateswaran RV, Singh A, Bhatt DL, Fonarow GC, Passman R, Butler J, Yancy CW, Vaduganathan M. The Current Landscape of Atrial Fibrillation and Atrial Flutter Clinical Trials: A Report of 348 Studies Registered With ClinicalTrials.gov. JACC Clin Electrophysiol. 2018 07; 4(7):944-954.
    View in: PubMed
    Score: 0.219
  35. Stern G, Rimsans J, Qamar A, Vaduganathan M, Bhatt DL. Contemporary parenteral antiplatelet bridging strategies: a single-centre real-world experience at a tertiary care centre. EuroIntervention. 2018 06 08; 14(3):e333-e335.
    View in: PubMed
    Score: 0.218
  36. Vaduganathan M, Nagarur A, Qamar A, Patel RB, Navar AM, Peterson ED, Bhatt DL, Fonarow GC, Yancy CW, Butler J. Availability and Use of Shared Data From Cardiometabolic Clinical Trials. Circulation. 2018 02 27; 137(9):938-947.
    View in: PubMed
    Score: 0.210
  37. Vaduganathan M, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL. Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX). Am J Cardiol. 2017 Oct 01; 120(7):1043-1048.
    View in: PubMed
    Score: 0.205
  38. Badreldin HA, Carter D, Cook BM, Qamar A, Vaduganathan M, Bhatt DL. Safety and Tolerability of Transitioning from Cangrelor to Ticagrelor in Patients Who Underwent Percutaneous Coronary Intervention. Am J Cardiol. 2017 Aug 01; 120(3):359-361.
    View in: PubMed
    Score: 0.202
  39. Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention. J Am Coll Cardiol. 2017 Jan 17; 69(2):176-185.
    View in: PubMed
    Score: 0.198
  40. Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP. Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment. J Am Coll Cardiol. 2016 08 30; 68(9):981-2.
    View in: PubMed
    Score: 0.193
  41. Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Bhatt DL. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial. Am J Med. 2016 Sep; 129(9):1002-5.
    View in: PubMed
    Score: 0.189
  42. Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. J Am Coll Cardiol. 2016 Apr 12; 67(14):1661-71.
    View in: PubMed
    Score: 0.187
  43. Tahhan AS, Vaduganathan M, Greene SJ, Alrohaibani A, Raad M, Gafeer M, Mehran R, Fonarow GC, Douglas PS, Bhatt DL, Butler J. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review. JAMA Cardiol. 2020 Mar 25.
    View in: PubMed
    Score: 0.062
  44. Wadhera RK, Vaduganathan M, Jiang GY, Song Y, Xu J, Shen C, Bhatt DL, Yeh RW, Fonarow GC. Performance in Federal Value-Based Programs of Hospitals Recognized by the American Heart Association and American College of Cardiology for High-Quality Heart Failure and Acute Myocardial Infarction Care. JAMA Cardiol. 2020 Feb 19.
    View in: PubMed
    Score: 0.061
  45. McCarthy CP, Vaduganathan M, Solomon E, Sakhuja R, Piazza G, Bhatt DL, Connors JM, Patel NK. Running thin: implications of a heparin shortage. Lancet. 2020 02 15; 395(10223):534-536.
    View in: PubMed
    Score: 0.061
  46. Arora S, Qamar A, Gupta P, Vaduganathan M, Chauhan I, Tripathi AK, Sharma VY, Bansal A, Fatima A, Jain G, Batra V, Tyagi S, Khandelwal L, Kaul P, Rao SV, Girish MP, Bhatt DL, Gupta MD. Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study. Clin Cardiol. 2019 Dec; 42(12):1140-1146.
    View in: PubMed
    Score: 0.060
  47. Raber I, McCarthy CP, Vaduganathan M, Bhatt DL, Wood DA, Cleland JGF, Blumenthal RS, McEvoy JW. The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet. 2019 05 25; 393(10186):2155-2167.
    View in: PubMed
    Score: 0.058
  48. Jogu HR, Arora S, Vaduganathan M, Qamar A, Pandey A, Chevli PA, Pansuriya TH, Ahmad MI, Dutta A, Sunkara PR, Qureshi W, Vasu S, Upadhya B, Bhatt DL, Januzzi JL, Herrington D. Wake Forest University long-term follow-up of type 2 myocardial infarction: The Wake-Up T2MI Registry. Clin Cardiol. 2019 Jun; 42(6):592-604.
    View in: PubMed
    Score: 0.058
  49. McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL, de Lemos JA, Yancy C, Fonarow GC, Pandey A. Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program. JAMA Netw Open. 2019 04 05; 2(4):e192987.
    View in: PubMed
    Score: 0.058
  50. Patel RB, Vaduganathan M, Mosarla RC, Venkateswaran RV, Bhatt DL, Bonow RO. Open Access Publishing and Subsequent Citations Among Articles in Major Cardiovascular Journals. Am J Med. 2019 09; 132(9):1103-1105.
    View in: PubMed
    Score: 0.057
  51. Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, Porterfield D, Blankstein R, Rosamond WD, Bhatt DL, Caughey MC. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Circulation. 2019 02 19; 139(8):1047-1056.
    View in: PubMed
    Score: 0.057
  52. Droppa M, Vaduganathan M, Venkateswaran RV, Singh A, Szumita PM, Roberts RJ, Qamar A, Hack L, Rath D, Gawaz M, Fuernau G, de Waha-Thiele S, Desch S, Schneider S, Ouarrak T, Jaffer FA, Zeymer U, Thiele H, Bhatt DL, Geisler T. Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial. Resuscitation. 2019 04; 137:205-212.
    View in: PubMed
    Score: 0.057
  53. Patel RB, Vaduganathan M, Bhatt DL, Bonow RO. Characterizing High-Performing Articles by Altmetric Score in Major Cardiovascular Journals. JAMA Cardiol. 2018 12 01; 3(12):1249-1251.
    View in: PubMed
    Score: 0.056
  54. Arora S, Stouffer GA, Kucharska-Newton A, Vaduganathan M, Qamar A, Matsushita K, Kolte D, Reynolds HR, Bangalore S, Rosamond WD, Bhatt DL, Caughey MC. Fifteen-Year Trends in Management and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Among Black and White Patients: The ARIC Community Surveillance Study, 2000-2014. J Am Heart Assoc. 2018 10 02; 7(19):e010203.
    View in: PubMed
    Score: 0.056
  55. McCarthy CP, Vaduganathan M, McCarthy KJ, Januzzi JL, Bhatt DL, McEvoy JW. Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment. JAMA Cardiol. 2018 07 01; 3(7):642-649.
    View in: PubMed
    Score: 0.055
  56. Pareek M, Vaduganathan M, Bhatt DL, Olsen MH. Reply: Intersection of fasting plasma glucose, adverse cardiac remodeling, and clinical outcomes. Int J Cardiol. 2018 02 01; 252:214-215.
    View in: PubMed
    Score: 0.053
  57. Pareek M, Bhatt DL, Vaduganathan M, Biering-Sørensen T, Qamar A, Diederichsen AC, Møller JE, Hindersson P, Leósdóttir M, Magnusson M, Nilsson PM, Olsen MH. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event. Eur J Prev Cardiol. 2017 10; 24(15):1648-1659.
    View in: PubMed
    Score: 0.051
  58. Pareek M, Vaduganathan M, Bhatt DL, Leósdóttir M, Olsen MH. Prognostic implications of fasting plasma glucose in subjects with echocardiographic abnormalities. Int J Cardiol. 2017 Aug 15; 241:423-429.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.